Showing results (111-120 of 1,983) with videos related to
Sort By:
Pageof 199
International Journal of Cancer|April 11, 2022
Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysisMeng Xiu, Pin Zhang, Xiang Wang, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 23, 2020
Dose-dense paclitaxel plus carboplatin vs. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancerQing Li, Jiani Wang, Yuxin Mu, et al.Scientific Reports|July 22, 2017
Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysisZongbi Yi, Fei Ma, Chunxiao Li, et al.Chinese Journal of Cancer|February 1, 2018
Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapyMeiying Li, Fei Ma, Jiayu Wang, et al.Current Problems in Cancer|May 25, 2020
Comparative efficacy and safety of CDK4/6 and PI3K/AKT/mTOR inhibitors in women with hormone receptor-positive, HER2-negative metastatic breast cancer: a systematic review and network meta-analysisYiqun Han, Jiayu Wang, Zijing Wang, et al.Frontiers in Oncology|March 15, 2021
Sex-Based Heterogeneity in the Clinicopathological Characteristics and Prognosis of Breast Cancer: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.Plos One|October 30, 2015
Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment ModalitiesRuoxi Hong, Zhen Dai, Wenjie Zhu, et al.Cancer Control : Journal of the Moffitt Cancer Center|October 16, 2021
Clinicopathological Characteristics and Prognosis of Squamous Cell Carcinoma of the Breast: A Population-Based AnalysisYiqun Han, Jiayu Wang, Zijing Wang, et al.International Journal of Cancer|June 14, 2023
The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 statusMingxia Jiang, Jiaxuan Liu, Qiao Li, et al.Expert Review of Anticancer Therapy|October 15, 2020
Metronomic therapy in advanced breast cancer and NSCLC: vinorelbine as a paradigm of recent progressBinghe Xu, Tao Sun, Shusen Wang, et al.Pageof 199